Science

ANAM is an FDA cleared and listed device for use in the assessment of cognitive function. It is a proven technology with over 30 years of demonstrated effectiveness in both healthy and clinical populations.

Studies have evaluated cognitive function or changes in cognition associated with:

• Alzheimer's Disease
• Athlete Injury and Fitness
• Dementia
• Cancer
• Environmental Stressors
• Exercise
• Fatigue/Sleep Deprivation
• Fibromyalgia
• Lupus
• Medications/Therapeutics
• Migraine headaches
• Multiple Sclerosis
• Parkinson's Disease
• Performance Capabilities
• Readiness-to-Perform
• Stress
• Sustained Operations
• Toxic Exposures
• Traumatic Brain Injury (TBI)

For more information, see Research and Publications.